what are glp-1 agonists receptor show promise in treating substance use disorders Current Insights, Advantages and Challenges
Description
Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, et al
GLP-1 receptors arent just found in the pancreas and brain
The FDA has raised red flags about unapproved versions of these medications
A patient with exenatide-associated acute-on-chronic renal failure requiring hemodialysis
Wegovy (semaglutide): Patients on the 2.4 mg dose lost an average of 15% of their body weight over 68 weeks
